Literature DB >> 8125145

A simple assay for detection of peptides promoting the assembly of HLA class I molecules.

F Connan1, F Hlavac, J Hoebeke, J G Guillet, J Choppin.   

Abstract

Synthetic peptides derived from influenza virus and human immunodeficiency virus were tested for their ability to promote the assembly of HLA-A2 and HLA-B51 molecules in T2 cell lysates. Specific assembly was detected by an enzyme-linked immunosorbent assay. The most significant HLA-A2 assembly was obtained in the presence of peptides known to be targets for HLA-A2-restricted cytotoxic T lymphocytes (influenza matrix M.58-66 and HIV Pol 476-484). Three of a batch of Nef peptides corresponding to epitopic regions for cytotoxic T lymphocytes, caused significant assembly of HLA-A2 (Nef 83-91, 137-145 and 144-153), but only at high concentrations (100 microM). As these peptides bound relatively weakly, it is unlikely that they are good candidates for HLA-A2-restricted CTL epitopes. Peptides matrix M.60-68, Nef 186-194, and Plasmodium falciparum sh.77-85 produced the most significant assembly of HLA-B51. These peptides have a dominant hydrophobic anchor residue (V, L. I) at position 9 that could occupy pocket "F". Our results also suggest that another hydrophobic residue (V, L) at position 3 or 4 may anchor to hydrophobic pocket "D" of HLA-B51. Proline at position 2 greatly increases HLA-B51 anchoring.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125145     DOI: 10.1002/eji.1830240344

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.

Authors:  G W Nelson; R Kaslow; D L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Authors:  A Rousseau; B Benyahia; J Dalmau; F Connan; J-G Guillet; J-Y Delattre; J Choppin
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.

Authors:  H Gahéry-Ségard; G Pialoux; B Charmeteau; S Sermet; H Poncelet; M Raux; A Tartar; J P Lévy; H Gras-Masse; J G Guillet
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 4.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

5.  Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.

Authors:  C Pique; F Connan; J P Levilain; J Choppin; M C Dokhélar
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Authors:  W M Cohen; A Bianco; F Connan; L Camoin; M Dalod; G Lauvau; E Ferriès; B Culmann-Penciolelli; P M van Endert; J P Briand; J Choppin; J G Guillet
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.

Authors:  I Bourgault Villada; M Moyal Barracco; S Berville; M L Bafounta; C Longvert; V Prémel; P Villefroy; E Jullian; T Clerici; B Paniel; B Maillère; J Choppin; J G Guillet
Journal:  Clin Exp Immunol       Date:  2009-07-30       Impact factor: 4.330

8.  Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.

Authors:  P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

9.  Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

Authors:  Muriel Andrieu; Jean-François Desoutter; Estelle Loing; Jésintha Gaston; Daniel Hanau; Jean-Gérard Guillet; Anne Hosmalin
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.